Leica, Dell form China pathology deal

| | Health Imaging | Artificial Intelligence

Leica Biosystems, through its acquisition of Aperio, will provide Chinese physicians access to U.S. healthcare organizations for real-time, expert review of pathology cases through a medical cloud network built in collaboration with Dell Healthcare and Life Sciences.

The U.S. institutions providing pathology services include: The Johns Hopkins Hospital in Baltimore; Cleveland Clinic; Hospital of the University of Pennsylvania in Philadelphia; Dianon in Shelton, Conn.; and ProPath in Dallas.

The cloud-based system is powered by Dell’s Unified Clinical Archive.

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.